| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $72.61 ▼ -3.08% | Yesterday | $74.92 • 0.00% | Tomorrow's Spyre Therapeutics Inc. Common Stock (SYRE) setup is anchored to $74.92 and targets $72.61 (-3.08%). The near-term read is downside; watch $77.73 / $72.11 because daily realized volatility is about 3.91%. |
Tomorrow's Spyre Therapeutics Inc. Common Stock (SYRE) setup is anchored to $74.92 and targets $72.61 (-3.08%). The near-term read is downside; watch $77.73 / $72.11 because daily realized volatility is about 3.91%. | ||||
| Week | $73.83 ▼ -1.45% | Last Week | $74.92 • 0.00% | The 7-day Spyre Therapeutics Inc. Common Stock model moves from $74.92 to $73.83 (-1.45%). It gives downside momentum context for this stock, so breaks around $77.73 / $72.11 matter more than a single tick. |
The 7-day Spyre Therapeutics Inc. Common Stock model moves from $74.92 to $73.83 (-1.45%). It gives downside momentum context for this stock, so breaks around $77.73 / $72.11 matter more than a single tick. | ||||
| Month | $76.69 ▲ +2.36% | Last Month | $74.92 • 0.00% | The 1-month Spyre Therapeutics Inc. Common Stock target is $76.69 (+2.36%), compared with the live reference near $74.92. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Spyre Therapeutics Inc. Common Stock target is $76.69 (+2.36%), compared with the live reference near $74.92. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $80.88 ▲ +7.96% | Last Year | $74.92 • 0.00% | The 1-year Spyre Therapeutics Inc. Common Stock scenario points to $80.88 (+7.96%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Spyre Therapeutics Inc. Common Stock scenario points to $80.88 (+7.96%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $90.45 ▲ +20.73% | 5 Years Ago | $74.92 • 0.00% | The 5-year Spyre Therapeutics Inc. Common Stock view is $90.45 (+20.73%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Spyre Therapeutics Inc. Common Stock view is $90.45 (+20.73%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 46.4 | Neutral |
| MACD | -0.07 | Bearish |
| SMA 50 | $74.65 | Mid |
| SMA 200 | $74.74 | Mid |
| EMA 20 | $74.80 | Mid |
| Opening Price | $74.92 | Start Date | 2021-05-17 |
| Day Range | $73.01 – $76.83 | Market Cap | $6.61B |
| Monthly Range | $71.40 – $80.29 | 24h Volume | n/a |
| 90D Range | $70.23 – $81.49 | Circulating | n/a |
| 52W Range | $68.76 – $87.53 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.